Contact
Please use this form to send email to PR contact of this press release:
Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd., Announces Results from Phase 3 Study, LUCIDITY, and Proceeds with Regulatory Submissions
TO: